Literature DB >> 24785101

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Thomas G Beach1, Jeremiah Carew2, Geidy Serrano2, Charles H Adler3, Holly A Shill2, Lucia I Sue2, Marwan N Sabbagh2, Haruhiko Akiyama4, Nicolás Cuenca5.   

Abstract

Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autopsy; Diagnosis; Ganglion cell; Lewy body; Melanopsin; Pathology

Mesh:

Substances:

Year:  2014        PMID: 24785101      PMCID: PMC4591751          DOI: 10.1016/j.neulet.2014.04.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  Pathoanatomy of Parkinson's disease.

Authors:  H Braak; E Braak
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  Visual symptoms in Parkinson's disease and Parkinson's disease dementia.

Authors:  Neil K Archibald; Mike P Clarke; Urs P Mosimann; David J Burn
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

3.  Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.

Authors:  Julián Esteve-Rudd; Laura Fernández-Sánchez; Pedro Lax; Emilio De Juan; José Martín-Nieto; Nicolás Cuenca
Journal:  Neurobiol Dis       Date:  2011-06-25       Impact factor: 5.996

4.  Protein aggregation in the aging retina.

Authors:  François Leger; Pierre-Olivier Fernagut; Marie-Hélène Canron; Sandy Léoni; Claude Vital; François Tison; Erwan Bezard; Anne Vital
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

5.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

6.  Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.

Authors:  Kimiko Obi; Haruhiko Akiyama; Hiromi Kondo; Yoko Shimomura; Masato Hasegawa; Takeshi Iwatsubo; Yoshikuni Mizuno; Hideki Mochizuki
Journal:  Exp Neurol       Date:  2007-12-03       Impact factor: 5.330

7.  Evaluation of alpha-synuclein immunohistochemical methods used by invited experts.

Authors:  Thomas G Beach; Charles L White; Ronald L Hamilton; John E Duda; Takeshi Iwatsubo; Dennis W Dickson; James B Leverenz; Federico Roncaroli; Manuel Buttini; Christa L Hladik; Lucia I Sue; Joseph V Noorigian; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-07-15       Impact factor: 17.088

8.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

Review 9.  Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function.

Authors:  Tiffany M Schmidt; Michael Tri H Do; Dennis Dacey; Robert Lucas; Samer Hattar; Anna Matynia
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

10.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522

View more
  40 in total

1.  Progressive retinal structure abnormalities in multiple system atrophy.

Authors:  Carlos E Mendoza-Santiesteban; Jose-Alberto Palma; Jose Martinez; Lucy Norcliffe-Kaufmann; Thomas R Hedges; Horacio Kaufmann
Journal:  Mov Disord       Date:  2015-09-11       Impact factor: 10.338

2.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

3.  Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy.

Authors:  Carlos E Mendoza-Santiesteban; Jose-Alberto Palma; Isabel Ortuño-Lizarán; Nicolás Cuenca; Horacio Kaufmann
Journal:  Neurology       Date:  2017-05-10       Impact factor: 9.910

Review 4.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

5.  Retinal thinning correlates with clinical severity in multiple system atrophy.

Authors:  Jeeyun Ahn; Jee-Young Lee; Tae Wan Kim
Journal:  J Neurol       Date:  2016-07-14       Impact factor: 4.849

6.  Self-perception and determinants of color vision in Parkinson's disease.

Authors:  Alexander U Brandt; Hanna G Zimmermann; Timm Oberwahrenbrock; Justine Isensee; Thomas Müller; Friedemann Paul
Journal:  J Neural Transm (Vienna)       Date:  2017-11-15       Impact factor: 3.575

7.  FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.

Authors:  Guadalupe Vidal-Martinez; Katherine Najera; Julie D Miranda; Carolina Gil-Tommee; Barbara Yang; Javier Vargas-Medrano; Valeria Diaz-Pacheco; Ruth G Perez
Journal:  Neuroscience       Date:  2019-05-23       Impact factor: 3.590

8.  In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients.

Authors:  Femke Visser; Koenraad A Vermeer; Babak Ghafaryasl; Annemarie M M Vlaar; Valentin Apostolov; Jan van Hellenberg Hubar; Henry C Weinstein; Johannes F de Boer; Henk W Berendse
Journal:  J Neural Transm (Vienna)       Date:  2018-03-08       Impact factor: 3.575

Review 9.  Chronotherapies for Parkinson's disease.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Prog Neurobiol       Date:  2019-01-15       Impact factor: 11.685

10.  Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.

Authors:  M Heather West Greenlee; Melissa Lind; Robyn Kokemuller; Najiba Mammadova; Naveen Kondru; Sireesha Manne; Jodi Smith; Anumantha Kanthasamy; Justin Greenlee
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.